Sogen Data · Datasets · 数据专题
胃癌复发轴数据集锦
bulk 转录组
本专题承自 Sogen Data 数据整理体系,逐条人工复核,附研究设计、样本量、平台与 GEO/PubMed 直达链接。
人源bulk 转录组
Human · Bulk RNA-seq
-
01 GSE26253 对接受根治性手术加辅助放化疗的胃癌患者,使用福尔马林固定石蜡包埋肿瘤组织(FFPET)进行基因表达分析,以识别高复发风险患者。研究采用 WG-DASL 技术检测总 RNA 表达,样本为 FFPE 胃腺癌组织,通过手动显微切割去除非肿瘤成分,提取 RNA 后根据浓度和纯度筛选合格样本。
设计对接受根治性手术加辅助放化疗的胃癌患者,使用福尔马林固定石蜡包埋肿瘤组织(FFPET)进行基因表达分析,以识别高复发风险患者。研究采用 WG-DASL 技术检测总 RNA 表达,样本为 FFPE 胃腺癌组织,通过手动显微切割去除非肿瘤成分,提取 RNA 后根据浓度和纯度筛选合格样本。
摘要Gastric cancer is the second most common cause of cancer-related death worldwide. Up to 80% of patients who undergo curative surgical resection develop locoregional or distant recurrence. A recent large-scaled meta-analysis on 3,838 patients from 17 trials has demonstrated survival benefit from adjuvant chemotherapy when compared to surgery alone. Furthermore, INT-0116 study has demonstrated a survival benefit from postoperative chemoradiation therapy with 5-fluorouracil and leucovorin in gastric cancer patients. Despite these advances, 5-year disease-free survival rates remain poor for patients diagnosed with stage III or IV gastric cancer (stage IIIA, 57.6%, stage IIIB, 39.6%; and stage IV 26.3%) underscoring the need for development of new targeted agents. On the other hand those diagnosed with stage Ib/II gastric cancer have moderate 5 year recurrence rate (76.2%) and suggest the presence of significant molecular heterogeneity with varying prognosis. We hypothesized that gene expression of profiling of formalin fixed paraffin embedded tumor (FFPET) samples using whole genome cDNA-mediated Annealing, Selection, Extension, and Ligation (WG-DASL) assay could be used to develop robust prognostic profiles for gastric cancer treated with chemoradiotherapy that are independent of clinicopathological features. We have identified and validated a gene expression signature that predicts recurrence after curative resection. We also performed pathway analyses to delineate aberrant pathways in aggressive gastric cancer which suggest targeted treatment strategies.
-
02 GSE15081 对141例接受根治性手术的胃癌患者进行RNA表达谱分析,其中56例用于回顾性研究,包含38例无复发和18例腹膜复发患者;85例用于前瞻性研究,包含无复发和腹膜复发患者以及部分被审查的患者。通过微阵列平台对RNA样本进行分析,构建分子预测系统并进行500次多重随机抽样验证其稳健性和预后有效性,随后应用于前瞻性研究以评估预测准确性和预后价值。
设计对141例接受根治性手术的胃癌患者进行RNA表达谱分析,其中56例用于回顾性研究,包含38例无复发和18例腹膜复发患者;85例用于前瞻性研究,包含无复发和腹膜复发患者以及部分被审查的患者。通过微阵列平台对RNA样本进行分析,构建分子预测系统并进行500次多重随机抽样验证其稳健性和预后有效性,随后应用于前瞻性研究以评估预测准确性和预后价值。
摘要Purpose: Our study aimed to disclose the specific gene expression profile representing peritoneal relapses inherent in primary gastric cancers and to identify patients at high risk of peritoneal relapse in a prospective study on the basis of the molecular prediction. Experimental Design: RNA samples from 141 primary gastric cancer tissues after curative surgery were profiled using oligonucleotide microarrays covering 30,000 human probes. Firstly we constructed molecular prediction system and validated the robustness and prognostic validity of the analysis by 500 times multiple random sampling in 56 retrospective set consisting of 38 relapse free and 18 peritoneal relapse patients. Secondly we applied this prediction to 85 prospective set to assess the predictive accuracy and prognostic validity. Results: In retrospective phase, 500 times multiple random sampling analysis yielded 68% predictive accuracy in average and 22 gene expression profile associated with peritoneal relapse was identified. This prediction could identify significantly poor prognostic patients. In prospective phase, the molecular prediction yielded 76.9% overall accuracy. Kaplan–Meier analysis with peritoneal relapse free survival showed a significant difference between ‘good signature group’ and ‘poor signature group’ (Log-rank p=0.0017). Multivariate analysis by Cox regression hazards model revealed that the molecular prediction was the only independent peritoneal relapse prognostic factor. Conclusions: Gene expression profile inherent in primary gastric cancer tissues can be useful to predict peritoneal relapse prospectively after curative surgery and individualize postoperative management to improve the prognosis of advanced gastric cancers.
-
03 GSE190449 对接受早期胃腺癌治疗并根除幽门螺杆菌后发生异时复发(MR)的5例患者及无复发的5例对照患者,分别从胃小弯近幽门处(LA)、胃大弯近幽门处(GA)、胃小弯体部中部(LB)和胃大弯体部中部(GB)采集活检样本进行RNA测序,比较MR组与对照组在各胃部部位的基因表达差异。
设计对接受早期胃腺癌治疗并根除幽门螺杆菌后发生异时复发(MR)的5例患者及无复发的5例对照患者,分别从胃小弯近幽门处(LA)、胃大弯近幽门处(GA)、胃小弯体部中部(LB)和胃大弯体部中部(GB)采集活检样本进行RNA测序,比较MR组与对照组在各胃部部位的基因表达差异。
摘要Even after endoscopic treatment of early gastric adenocarcinoma (GAC) and eradication of Helicobacter pylori (H. pylori), some patients develop a metachronous recurrence (MR), the mechanism of which is still unknown. To elucidate the mechanism and risk factors for MR, we analyzed gene expression at multiple locations of the gastric mucosa, considering the heterogeneity of gastric mucosal damage caused by H. pylori infection and investigated the mechanism and risk factors for MR.

课题合作 · 扫码加微信
bioinformaticsboy